These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 22140532)
1. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells. Magistroni V; Mologni L; Sanselicio S; Reid JF; Redaelli S; Piazza R; Viltadi M; Bovo G; Strada G; Grasso M; Gariboldi M; Gambacorti-Passerini C PLoS One; 2011; 6(11):e28162. PubMed ID: 22140532 [TBL] [Abstract][Full Text] [Related]
2. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. Kim J; Roh M; Abdulkadir SA BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470 [TBL] [Abstract][Full Text] [Related]
3. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis. Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722 [TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of the ERG transcription factor in prostate cancer cells activates osteopontin. Flajollet S; Tian TV; Flourens A; Tomavo N; Villers A; Bonnelye E; Aubert S; Leroy X; Duterque-Coquillaud M Mol Cancer Res; 2011 Jul; 9(7):914-24. PubMed ID: 21669963 [TBL] [Abstract][Full Text] [Related]
5. High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer. Smit FP; Salagierski M; Jannink S; Schalken JA BJU Int; 2013 May; 111(5):836-42. PubMed ID: 23578236 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions. Singareddy R; Semaan L; Conley-Lacomb MK; St John J; Powell K; Iyer M; Smith D; Heilbrun LK; Shi D; Sakr W; Cher ML; Chinni SR Mol Cancer Res; 2013 Nov; 11(11):1349-61. PubMed ID: 23918819 [TBL] [Abstract][Full Text] [Related]
7. Expression and ERG regulation of PIM kinases in prostate cancer. Eerola SK; Kohvakka A; Tammela TLJ; Koskinen PJ; Latonen L; Visakorpi T Cancer Med; 2021 May; 10(10):3427-3436. PubMed ID: 33932111 [TBL] [Abstract][Full Text] [Related]
8. TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation. Mounir Z; Lin F; Lin VG; Korn JM; Yu Y; Valdez R; Aina OH; Buchwalter G; Jaffe AB; Korpal M; Zhu P; Brown M; Cardiff RD; Rocnik JL; Yang Y; Pagliarini R Oncogene; 2015 Jul; 34(29):3815-25. PubMed ID: 25263440 [TBL] [Abstract][Full Text] [Related]
9. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Tomlins SA; Laxman B; Varambally S; Cao X; Yu J; Helgeson BE; Cao Q; Prensner JR; Rubin MA; Shah RB; Mehra R; Chinnaiyan AM Neoplasia; 2008 Feb; 10(2):177-88. PubMed ID: 18283340 [TBL] [Abstract][Full Text] [Related]
10. TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer. Swanson TA; Krueger SA; Galoforo S; Thibodeau BJ; Martinez AA; Wilson GD; Marples B Prostate; 2011 Oct; 71(14):1548-58. PubMed ID: 21394739 [TBL] [Abstract][Full Text] [Related]
11. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase. Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079 [TBL] [Abstract][Full Text] [Related]
12. ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents. Mancarella C; Casanova-Salas I; Calatrava A; Ventura S; Garofalo C; Rubio-Briones J; Magistroni V; Manara MC; López-Guerrero JA; Scotlandi K Oncotarget; 2015 Jun; 6(18):16611-22. PubMed ID: 25906745 [TBL] [Abstract][Full Text] [Related]
13. TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation. Casey OM; Fang L; Hynes PG; Abou-Kheir WG; Martin PL; Tillman HS; Petrovics G; Awwad HO; Ward Y; Lake R; Zhang L; Kelly K PLoS One; 2012; 7(7):e41668. PubMed ID: 22860005 [TBL] [Abstract][Full Text] [Related]
14. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer. Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414 [TBL] [Abstract][Full Text] [Related]
15. Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma. Camões MJ; Paulo P; Ribeiro FR; Barros-Silva JD; Almeida M; Costa VL; Cerveira N; Skotheim RI; Lothe RA; Henrique R; Jerónimo C; Teixeira MR PLoS One; 2012; 7(11):e49819. PubMed ID: 23185447 [TBL] [Abstract][Full Text] [Related]
16. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models. Linn DE; Bronson RT; Li Z PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911 [TBL] [Abstract][Full Text] [Related]
17. 5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancer. Zammarchi F; Boutsalis G; Cartegni L PLoS One; 2013; 8(3):e49721. PubMed ID: 23472063 [TBL] [Abstract][Full Text] [Related]
18. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia. Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217 [TBL] [Abstract][Full Text] [Related]
19. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer. Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826 [TBL] [Abstract][Full Text] [Related]
20. N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Pflueger D; Rickman DS; Sboner A; Perner S; LaFargue CJ; Svensson MA; Moss BJ; Kitabayashi N; Pan Y; de la Taille A; Kuefer R; Tewari AK; Demichelis F; Chee MS; Gerstein MB; Rubin MA Neoplasia; 2009 Aug; 11(8):804-11. PubMed ID: 19649210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]